Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Coeptis Therapeutics Holdings (COEP) Depreciation & Amortization (IS) (2023 - 2025)

Coeptis Therapeutics Holdings (COEP) has 3 years of Depreciation & Amortization (IS) data on record, last reported at $250000.0 in Q2 2025.

  • For Q2 2025, Depreciation & Amortization (IS) changed 0.0% year-over-year to $250000.0; the TTM value through Jun 2025 reached $1.0 million, changed 0.0%, while the annual FY2024 figure was $1.0 million, 0.0% changed from the prior year.
  • Depreciation & Amortization (IS) reached $250000.0 in Q2 2025 per COEP's latest filing, roughly flat from $250000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $250000.0 in Q1 2023 and bottomed at $250000.0 in Q1 2023.
  • Average Depreciation & Amortization (IS) over 3 years is $250000.0, with a median of $250000.0 recorded in 2023.
  • The widest YoY moves for Depreciation & Amortization (IS): up 0.0% in 2024, down 0.0% in 2024.
  • A 3-year view of Depreciation & Amortization (IS) shows it stood at $250000.0 in 2023, then changed by 0.0% to $250000.0 in 2024, then changed by 0.0% to $250000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (IS) were $250000.0 in Q2 2025, $250000.0 in Q1 2025, and $250000.0 in Q4 2024.